Wanlei Yang

653 total citations
25 papers, 487 citations indexed

About

Wanlei Yang is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Wanlei Yang has authored 25 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cell Biology and 6 papers in Oncology. Recurrent topics in Wanlei Yang's work include Bone Metabolism and Diseases (9 papers), Hippo pathway signaling and YAP/TAZ (8 papers) and Bone health and treatments (4 papers). Wanlei Yang is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Hippo pathway signaling and YAP/TAZ (8 papers) and Bone health and treatments (4 papers). Wanlei Yang collaborates with scholars based in China and Australia. Wanlei Yang's co-authors include Weiqi Han, Yu Qian, An Qin, Xuanyuan Lu, Tan Zhang, Wei He, Yewei Jia, Jiake Xu, Ziyi Wang and Jirong Wang and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Wanlei Yang

22 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanlei Yang China 13 246 112 90 69 69 25 487
Weiqi Han China 14 239 1.0× 98 0.9× 86 1.0× 49 0.7× 34 0.5× 24 454
Heike Kaltenegger Austria 12 184 0.7× 40 0.4× 47 0.5× 73 1.1× 53 0.8× 21 403
A Rum Kim South Korea 11 280 1.1× 267 2.4× 146 1.6× 55 0.8× 32 0.5× 12 622
Peipei Duan China 12 291 1.2× 37 0.3× 73 0.8× 45 0.7× 61 0.9× 27 582
Duenpim Parisuthiman United States 7 184 0.7× 69 0.6× 65 0.7× 47 0.7× 50 0.7× 9 371
Ludovic Micallef France 9 209 0.8× 106 0.9× 46 0.5× 98 1.4× 28 0.4× 12 694
Dong-Hyun Seo South Korea 13 221 0.9× 30 0.3× 70 0.8× 46 0.7× 54 0.8× 23 409
Muliang Ding China 14 339 1.4× 67 0.6× 60 0.7× 136 2.0× 36 0.5× 31 631
Xiangguo Che South Korea 11 231 0.9× 41 0.4× 37 0.4× 31 0.4× 38 0.6× 37 417

Countries citing papers authored by Wanlei Yang

Since Specialization
Citations

This map shows the geographic impact of Wanlei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanlei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanlei Yang more than expected).

Fields of papers citing papers by Wanlei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanlei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanlei Yang. The network helps show where Wanlei Yang may publish in the future.

Co-authorship network of co-authors of Wanlei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wanlei Yang. A scholar is included among the top collaborators of Wanlei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanlei Yang. Wanlei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Xin, et al.. (2025). Role of YAP/TAZ in bone diseases: A transductor from mechanics to biology. Journal of Orthopaedic Translation. 51. 13–23. 6 indexed citations
3.
Chen, Xin, et al.. (2025). Pharmacological regulators of Hippo pathway: Advances and challenges of drug development. The FASEB Journal. 39(6). e70438–e70438. 2 indexed citations
4.
Hu, Xinhua, et al.. (2025). Roles of myokines in osteoporosis under physiological and diabetic conditions. Frontiers in Endocrinology. 16. 1600218–1600218.
5.
Pan, Bin, et al.. (2025). Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis. Frontiers in Endocrinology. 15. 1486188–1486188. 3 indexed citations
6.
Chen, Zhuolin, Xuanyuan Lu, Jiewen Zheng, et al.. (2024). Targeted inhibition of STAT3 (Tyr705) by xanthatin alleviates osteoarthritis progression through the NF-κB signaling pathway. Biomedicine & Pharmacotherapy. 174. 116451–116451. 7 indexed citations
7.
Xu, Rongjian, Xuewen Liu, Yufeng Zhang, et al.. (2023). Activating transcriptional coactivator with PDZ-binding motif by (R)-PFI-2 attenuates osteoclastogenesis and prevents ovariectomized-induced osteoporosis. Biochemical Pharmacology. 219. 115964–115964. 4 indexed citations
8.
Yang, Wanlei, Xuanyuan Lu, Tan Zhang, et al.. (2021). TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling. Bone Research. 9(1). 33–33. 42 indexed citations
9.
Zhu, Jiling, Peng Sun, Qichang Yang, et al.. (2020). <p>Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo</p>. Drug Design Development and Therapy. Volume 14. 3435–3447. 15 indexed citations
10.
Zhang, Tan, Lei He, Wanlei Yang, et al.. (2020). Byakangelicin inhibits IL-1β–induced mouse chondrocyte inflammation in vitro and ameliorates murine osteoarthritis in vivo. International Immunopharmacology. 85. 106605–106605. 12 indexed citations
11.
Jia, Yewei, Jiawei Jiang, Xuanyuan Lu, et al.. (2018). Garcinol suppresses RANKL‐induced osteoclastogenesis and its underlying mechanism. Journal of Cellular Physiology. 234(5). 7498–7509. 18 indexed citations
12.
Lu, Xuanyuan, Wei He, Wanlei Yang, et al.. (2018). Dual effects of baicalin on osteoclast differentiation and bone resorption. Journal of Cellular and Molecular Medicine. 22(10). 5029–5039. 15 indexed citations
13.
Chen, Huan, et al.. (2017). miR-141-3p Suppresses Expression of Androgen Receptors and Functions as a Tumor Suppressor Gene in Prostate Carcinogenesis. International Journal of Clinical Medicine. 8(2). 55–72. 4 indexed citations
14.
Yang, Wanlei, Weiqi Han, An Qin, et al.. (2017). The emerging role of Hippo signaling pathway in regulating osteoclast formation. Journal of Cellular Physiology. 233(6). 4606–4617. 77 indexed citations
15.
Yang, Wanlei, et al.. (2017). Applied anatomic study of narrow pedicle in thoracolumbar spine of adults. Zhonghua guke zazhi. 37(1). 36–43. 1 indexed citations
16.
Yang, Wanlei, et al.. (2017). Minimally invasive percutaneous osteosynthesis versus ORIF for Sanders type II and III calcaneal fractures: a prospective, randomized intervention trial. Journal of Orthopaedic Surgery and Research. 12(1). 10–10. 40 indexed citations
17.
Li, Xiucheng, Zhifan Yang, Weiqi Han, et al.. (2017). Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways. International Journal of Molecular Medicine. 40(2). 311–318. 22 indexed citations
18.
Han, Weiqi, Wei He, Wanlei Yang, et al.. (2016). The osteogenic potential of human bone callus. Scientific Reports. 6(1). 36330–36330. 11 indexed citations
19.
Liu, Mei, Lianwen Yuan, Wei Shi, et al.. (2016). SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions. Cancer Letters. 386. 1–11. 26 indexed citations
20.
Yang, Wanlei, Weiqi Han, Wei He, et al.. (2015). Surface topography of hydroxyapatite promotes osteogenic differentiation of human bone marrow mesenchymal stem cells. Materials Science and Engineering C. 60. 45–53. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026